Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc. (SUPN)
Filing Type: Form 8-K (Current Report)
Date of Report: November 3, 2021
Reporting Period: Third quarter ended September 30, 2021
Context: This filing serves to announce the issuance of a press release regarding the Company's financial results for the third quarter of 2021. The detailed financial data is contained in Exhibit 99.1 (Press Release) and is not explicitly detailed within the body of this 8-K text.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the press release furnished as Exhibit 99.1, which is incorporated by reference but not reproduced in the input text.
Material Changes
The filing text does not provide specific data points to compare against the prior comparable period. It only confirms that results for the third quarter ended September 30, 2021, have been issued.
Guidance, Outlook, and Risks
- Management Commentary: The Company hosted a conference call on November 3, 2021, at 4:30 p.m. Eastern Time to present business and financial results. A webcast was made available on the Company's website.
- Forward-Looking Statements: The filing contains forward-looking statements regarding plans, strategies, and intentions. These are subject to risks and uncertainties, including those detailed in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020.
- Legal Disclaimer: Information furnished under Item 2.02 and Item 9.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q3 2021.
- Access the archived webcast on the Company's website for management's detailed commentary on the results.
- Consult the Form 10-K filed on March 8, 2021, for a comprehensive list of risk factors affecting forward-looking statements.
- Verify the Company's liquidity position and debt obligations in the full financial statements referenced in the press release.